http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102365371-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2267-0356 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2227-105 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2207-35 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5088 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K67-027 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01K67-027 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50 |
| filingDate | 2021-04-15^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2022-02-24^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2022-02-24^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-102365371-B1 |
| titleOfInvention | Information offering method for young adulthood depression using Iba-1, TNF-α, IL-1β and GFAP |
| abstract | The present invention relates to a method and composition for diagnosing adolescent depression using GFAP, and the present invention can diagnose adolescent depression by measuring the presence or amount of glial fibrillary acid protein (GFAP) in a human biological sample, Through this, it has a useful effect to ensure that appropriate medical measures can be taken for patients in need of treatment for adolescent depression, and can also be usefully used as a biomarker for analyzing the cause and pathology of adolescent depression and developing a treatment for depression. |
| priorityDate | 2018-10-26^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Showing number of triples: 1 to 514 of 514.